APA Citation

Santos, F. P. S., Lisboa, B., Datoguia, T. S., Helman, R., Pereira, W. O., Puga, R. D., . . . Campregher, P. V. (2014). Incidence and impact of activating mutations of the RAS-RAF- MEK-ERK pathway in patients with philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative disorders-unclassified (MDS/MPD-U).

Chicago Style Citation

Santos, Fabio P. S., et al. Incidence and Impact of Activating Mutations of the RAS-RAF- MEK-ERK Pathway in Patients With Philadelphia-negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/myeloproliferative Disorders-unclassified (MDS/MPD-U). 2014.

MLA Citation

Santos, Fabio P. S., et al. Incidence and Impact of Activating Mutations of the RAS-RAF- MEK-ERK Pathway in Patients With Philadelphia-negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/myeloproliferative Disorders-unclassified (MDS/MPD-U). 2014.

Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero , which allows the automatic upload of Oasisbr references.